Natco Pharma Limited Approves Interim Dividend for the Year 2015-2016; Approves Appointment of S. V. V. N. Appa Rao as Chief Financial Officer
The company also approved Interim CFO Mr. S. V. V. N. Appa Rao appointed as Chief Financial Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
976 INR | -2.44% | -5.07% | +20.78% |
05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
1st Jan change | Capi. | |
---|---|---|
+20.78% | 2.16B | |
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |